financetom
Business
financetom
/
Business
/
Opendoor Stock Gains Ground: What's Behind The Recent Momentum?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Opendoor Stock Gains Ground: What's Behind The Recent Momentum?
Nov 12, 2025 11:04 AM

Opendoor Technologies Inc ( OPEN ) shares are trading higher on Wednesday. The CEO of the real estate iBuying platform said he fully supports President Donald Trump’s 50-year mortgage plan, which aims to ease the housing affordability crisis in America.

OPEN is trading at elevated levels. See what is driving the movement here.

What To Know: During a Tuesday appearance on Fox Business’ “Making Money,” CEO Kaz Nejatian characterized the administration’s mortgage initiative as bullish for the real estate industry. According to Nejatian, the action tackles student loan debt, one of the largest obstacles facing prospective homeowners.

Nejatian cited the heavy burden of student loans on young adults when discussing the difficulty that the average person currently faces when purchasing a home. He criticized traditional mortgages for not meeting the needs of regular Americans and proposed an extended mortgage term that will “allow people to get their foot in the door.”

"If you believe that America is better when people own their homes, it is incredibly important to try a lot of different things to get people into homes," Nejatian said, praising the administration’s willingness to try new tools to improve housing access.

Prominent experts, however, have opposed the plan. Betsey Stevenson, once a member of former President Barack Obama’s Council of Economic Advisers, cautioned about the high costs involved, pointing out that since payments will be riddled with interest, people will be making very little equity contributions to their homes.

According to Brandon Avedikian, a realtor and the founder of Aspire Commercial, buyers would be better off renting rather than taking out a 50-year mortgage while undergoing significant repairs.

The news comes after Nejatian announced earlier this week that he would purchase $1 million worth of company shares, declaring on X that he and his family would buy stock on the first day regulations allowed them to do so. The planned purchase announcement came after Opendoor ( OPEN ) released its third-quarter results.

JPMorgan analyst Dae Lee maintained an Overweight rating and price target of $8 for December 2026 in response to the quarter, viewing the company’s current reset as essential preparation for long-term profitability under new management’s volume-driven strategy.

OPEN Price Action: Opendoor ( OPEN ) shares were up 1.30% at $8.58 at the time of publication on Wednesday, according to Benzinga Pro.

Read Next:

Opendoor ( OPEN ) CEO Pledges $1 Million Stock Buy — Puts His Money Where His Mouth Is

Image: Around the World Photos/Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bicara Therapeutics Inc IPOs Tomorrow, Here's What You Need To Know
Bicara Therapeutics Inc IPOs Tomorrow, Here's What You Need To Know
Sep 12, 2024
Bicara Therapeutics Inc (NASDAQ:BCAX) IPO will take place September, 13 on the NASDAQ exchange under the ticker BCAX. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 12, 2025. See also: Benzinga IPO Calendar About Bicara Therapeutics Inc Bicara Therapeutics Inc is a...
Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
Sep 12, 2024
Thursday, Gilead Sciences, Inc. ( GILD ) revealed the results of an interim analysis from a second Phase 3 trial investigating the use of the company’s twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir. Lenacapavir reduced HIV infections by 96% compared to background HIV incidence (bHIV). There were two incident cases among 2,180 participants, corresponding to 99.9% of participants not acquiring HIV...
Wall Street regulator set to vote on new 'tick sizes' rule
Wall Street regulator set to vote on new 'tick sizes' rule
Sep 12, 2024
Sept 12 (Reuters) - Wall Street's top regulator is due to vote next week on proposed new regulations to allow the pricing of stocks in increments of less than a penny, part of a pending structural overhaul of equities markets, a Thursday scheduling announcement showed. The five-member U.S. Securities and Exchange Commission will consider adopting new rules on minimum pricing...
Amazon boosts pay for its drivers following threats to unionize, WSJ reports
Amazon boosts pay for its drivers following threats to unionize, WSJ reports
Sep 12, 2024
Sept 12 (Reuters) - Amazon.com ( AMZN ) is putting billions of dollars toward the drivers that deliver its packages following union organizing activity among such workers, the Wall Street Journal reported on Thursday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved